文献速递乳房整形与再造

两步法假体乳房再造中皮瓣交换时常规瘢痕组织学检查的效用与成本效益

Utility and Cost Effectiveness of Routine, Histologic Evaluation of the Mastectomy Scar in Two-Stage, Implant-Based Reconstruction during Expander-to-Implant Exchange.
PubMed 文献 · Plast Reconstr Surg · 2018-01-01

每侧乳房组织学检查总费用为602美元。结论认为在立即分期再造队列中可安全避免常规瘢痕组织学分析。

要点

  • 立即分期假体再造中,瘢痕内临床沉默复发至多罕见。
  • 常规瘢痕组织学检查每侧乳房费用为602美元。
  • 可安全避免对乳房切除瘢痕的常规组织学分析。

核心结论

  • 在立即分期假体乳房再造队列中,常规乳房切除瘢痕组织学分析可安全避免。

主要发现

  • 所有瘢痕病理结果均为瘢痕内复发阴性。
  • 353侧乳房因癌行乳房切除,94侧因种系突变,15侧因高风险病变,6侧因高家族风险,179侧为对侧对称/风险降低。
  • 乳房切除/扩张器置入时平均年龄为47.7±10.3岁,扩张器置入至假体交换平均时间为254±152天。
  • 每侧乳房组织学检查总费用为602美元。

临床怎么用

  • 在立即分期假体再造患者扩张器换假体时,可避免常规行乳房切除瘢痕组织学检查。

局限性

  • 证据等级为治疗性IV级,为回顾性单医生系列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Routine histologic analysis of the mastectomy scar is well studied in the delayed breast construction population; no data regarding its utility in the immediate, staged reconstruction cohort have been published. METHODS: A retrospective review of all of the senior author's (C.D.C.) patients who underwent immediate, staged reconstruction was performed. The mastectomy scar was analyzed routinely at the time of expander-to-implant exchange. Six hundred forty-seven breasts were identified. The mastectomy scar, time between expander and permanent implant, average patient age, and mastectomy indication were calculated. A cost analysis was completed. RESULTS: All scar pathologic results were negative for in-scar recurrence. The majority, 353 breasts, underwent mastectomy for carcinoma, 94 for germline mutations, 15 for high-risk lesions, six for high family risk, and 179 for contralateral symmetry/risk reduction. The average age at mastectomy/expander placement was 47.7 ± 10.3 years, and the average time between expander placement and implant exchange was 254 ± 152 days. The total histologic charge per breast was $602. CONCLUSIONS: A clinically silent in-scar recurrence is, at most, a rare occurrence. Routine histologic analysis of the mastectomy scar can be safely avoided in the immediate, staged reconstruction cohort. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Fishman JE, Pang JHY, Dabbs D, et al. Utility and Cost Effectiveness of Routine, Histologic Evaluation of the Mastectomy Scar in Two-Stage, Implant-Based Reconstruction during Expander-to-Implant Exchange. Plast Reconstr Surg. 2018. PMID: 30489512. doi:10.1097/PRS.0000000000004971

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。